articles
- Normal human lymph node T follicular helper cells and germinal center B cells accessed via fine needle aspirations. 479. 2020
- Fluorescence-based measurement of cystine uptake through xCT shows requirement for ROS detoxification in activated lymphocytes. 438:51-58. 2016
- Selection of a potential diagnostic biomarker for HIV infection from a random library of non-biological synthetic peptoid oligomers. 435:85-89. 2016
- A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis. 417:34-44. 2015
- Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes. 422:28-34. 2015
- Mouse models for dengue vaccines and antivirals. 410:34-38. 2014
- Discovery of biomarkers for systemic lupus erythematosus using a library of synthetic autoantigen surrogates. 402:23-34. 2014
- Optimization of peptide arrays for studying antibodies to hepatitis C virus continuous epitopes. 402:35-42. 2014
- A mammalian expression system for high throughput antibody screening. 395:45-53. 2013
- Domestic cat microsphere immunoassays: detection of antibodies during feline immunodeficiency virus infection. 396:74-86. 2013
- A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples. 366:8-19. 2011
- A method for identification of hiv gp140 binding memory b cells in human blood. 343:65-67. 2009
- Multiplexed labeling of samples with cell tracking dyes facilitates rapid and accurate internally controlled calcium flux measurement by flow cytometry. 350:194-199. 2009
- Chimeric rabbit/human Fab and IgG specific for members of the Nogo-66 receptor family selected for species cross-reactivity with an improved phage display vector. 318:75-87. 2007
- A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells. 312:34-39. 2006
- A novel ELISA for mouse activated protein C in plasma. 314:174-181. 2006
- Co-expression of antibody fab heavy and light chain genes from separate evolved compatible replicons in E. coli. 317:56-63. 2006
- Molecular characterization of the circulating anti-hiv-1 gp120-specific b cell repertoire using antibody phage display libraries generated from pre-selected hiv-1 gp120 binding pbls. 297:187-201. 2005
- Human/mouse cross-reactive anti-VEGF receptor 2 recombinant antibodies selected from an immune b9 allotype rabbit antibody library. 288:149-164. 2004
- Isolation of human prostate cancer cell reactive antibodies using phage display technology. 291:137-151. 2004
- A simple method for detecting up to five immunofluorescent parameters together with DNA staining for cell cycle or viability on a benchtop flow cytometer. 275:113-121. 2003
- De novo identification of tumor-specific internalizing human antibody-receptor pairs by phage-display methods. 274:185-197. 2003
- Tandem IMAC-HPLC purification of a cocaine-binding scFv antibody. 281:143-148. 2003
- Reactive immunization: A unique approach to catalytic antibodies. 269:67-79. 2002
- Facile generation and use of immunogenic polypeptide fusions to a sparingly soluble non-antigenic protein carrier. 236:53-69. 2000
- Methods for the generation of chicken monoclonal antibody fragments by phage display. 242:159-181. 2000
- Selection of phage-displayed superantigen by binding to cell-surface mhc class ii. 204:33-41. 1997
- Simple affinity purification of antibodies using in vivo biotinylation of a fusion protein. 207:147-155. 1997
- Comparison of protocols for depleting anti-E. coli antibody in immunoblotting of recombinant antigens. 190:143-145. 1996
- Prediction of binding to mhc class-i molecules. 185:181-190. 1995
- Surface-plasmon resonance based kinetic-studies of zinc-finger DNA interactions. 183:175-182. 1995
- Radioimmunoassay versus flow cytometric assay to quantify LPS-binding protein (LBP) concentrations in human plasma. 171:169-176. 1994
- Receptor-mediated label-transfer assay (relay) - a novel method for the detection of plasma tumor-necrosis-factor at attomolar concentrations. 169:93-99. 1994
- A sensitive elisa for measuring recombinant human interleukin-3 in human plasma or serum. 145:161-165. 1991
- Effective separation of the 52 kDa SSA/Ro polypeptide from the 48 kDa SSB/La polypeptide by altering conditions of polyacrylamide gel electrophoresis. 129:207-210. 1990
- Increased yield of antibody-producing murine spleen-cell hybridomas from fusions cultured in medium supplemented with mouse serum. 127:39-42. 1990
- Inhibition of antibody-production at high cell-density following mitogen stimulation and isotype switching in vitro. 119:9-17. 1989
- Anti-hv3 peptide antibodies as probes for conformational-changes in immunoglobulins. 114:13-20. 1988
- Evaluation of monoclonality of cell-lines from sequential dilution assays .2. 107:151-152. 1988
- Microassay for measurement of binding of radiolabeled ligands to cell-surface molecules. 111:205-207. 1988
- Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. 109:49-59. 1988
- A new method for reduction of endotoxin contamination from protein solutions. 105:211-220. 1987
- Evaluation of monoclonality of cell-lines from sequential dilution assays. 105:139-143. 1987
- A quantitative dot immunobinding assay for human HLA class II antigens using nitrocellulose membrane filters. 89:73-79. 1986
- Amidolytic assay for procoagulant activity of lymphoid and tumor-cells. 89:131-139. 1986
- Direct quantitation of activated c-3 in human-plasma with monoclonal anti-ic3b-c3d-neoantigen. 88:33-36. 1986
- Monoclonal antibody for DNA measurement in biological fluids. 88:185-192. 1986
- Quantitation of epstein-barr-virus (ebv)-determined nuclear antigen (ebna) by a 2-site enzyme-immunoassay, in parallel with ebv-DNA. 89:151-158. 1986
- Rapid recovery of non-hemolyzed serum and untraumatized cells by using a new method of blood defibrination in vitro. 92:251-260. 1986
- Immunodetection of cell-bound antigens using both mouse and human monoclonal-antibodies. 81:115-122. 1985
- Selective binding of heat- and antigen-aggregated IgG to Blue Sepharose. Radioimmunoassay of circulating immune complexes. 76:395-396. 1985
- Identification of the SS-A/Ro intracellular antigen with autoimmune sera. 71:217-228. 1984
- Production and detection of monoclonal anti-idiotype antibodies directed against a monoclonal anti-beta-adrenergic ligand antibody. 74:163-171. 1984
- An improved ELISA for anti-native DNA by elimination of interference by anti-histone antibodies. 63:359-366. 1983
- Computer-assisted analysis of in vivo cytotoxic T cell responses. 64:91-98. 1983
- Association of human and bovine beta-2-microglobulins with detergent solubilized hla-a,b antigens. 52:97-104. 1982
- Human histocompatibility antigens - isolation and chemical characterization. 49:R25-R50. 1982
- Partial-purification of anti-DNA antibodies from systemic lupus-erythematosus serum by dye-ligand chromatography. 54:81-94. 1982
- Human-melanoma associated antigens - a solid-phase assay for detection of specific antibody. 39:233-246. 1980
- Antibody-coated protein a-bearing staphylococcus-aureus - versatile and stable immune reagent. 25:255-264. 1979
- Microassay for determination of hemolytic complement activity in mouse serum. 22:273-281. 1978
- Semiautomatic solid-phase radioimmunoassay for carcinoembryonic antigen. 18:157-164. 1977
- Detection of complement activation by counterimmunoelectrophoresis (CIE). 13:101-112. 1976
- Isolation of human t-lymphocytes and b-lymphocytes by rosette formation with 2-aminoethylisothiouronium bromide (aet) - treated sheep red blood-cells and with monkey red blood-cells. 11:273-279. 1976
- Micro-hemagglutination tests for detection of native and single-strand DNA antibodies and circulating DNA antigen. 3:287-300. 1973